Shorter maintenance therapy in childhood acute lymphoblastic leukemia: The experience of the prospective, randomized Brazilian GBTLI ALL-93 Protocol

16Citations
Citations of this article
43Readers
Mendeley users who have this article in their library.

Abstract

Aim: Maintenance therapy is an important phase of the childhood ALL treatment, requiring 2-year long therapy adherence of the patients and families. Weekly methotrexate with daily 6-mercaptopurine (6MP) constitutes the backbone of maintenance therapy. Reduction in the maintenance therapy could overweight problems related with poverty of children with ALL living in limited-income countries (LIC). Objective: To compare, prospectively, the EFS rates of children with ALL treated according to two maintenance regimens: 18 vs. 24 months duration. Materials and methods: From October 1993 to September 1999, 867 consecutive untreated ALL patients < 18 years of age were treated according to the Brazilian Cooperative Group for Childhood ALL Treatment (GBTLI) ALL-93 protocol. Risk classification was based exclusively on patient's age and leukocyte count (NCI risk group) and clinical extra medullary involvement of the disease. Data were analyzed by the intention-to-treat approach. Results: Fourteen patients (1.6%) were excluded: wrong diagnosis (n = 7) and previous corticosteroid (n = 7). Of the 853 eligible patients, 421 were randomly allocated, at study enrollment, to receive 18-month (group 1) and 432 to receive 24-month (group 2) maintenance therapy. Complete remission rate was achieved in 96% of the patients (817/853). Twenty-eight patients (3.4%) died during the induction phase. Thirty-four patients (4.0%) were lost to follow-up. The overall EFS was 66.1 ± 1.7% at 15 years. No difference was seen according to maintenance: EFS15y was 65.8 ± 2.3% (group 1) and 66.3 ± 2.3% (group 2; p = 0.79). No difference between regimens was detected after stratifying the analyses according to factors associated with adverse prognosis in this study (age group < 1 year or > 10 years and high WBC at diagnosis). Overall death in remission rate was 6.85% (56 patients). Deaths during maintenance were 13 in group 1 and 12 in group 2, all due to infection. Over 15 years of follow-up, two patients both from group 2 presented a second malignancy (Hodgkin's disease and thyroid carcinoma) after 8.3 and 11 years off therapy, respectively. Conclusion: Six-month reduction of maintenance therapy in ALL children treated according to the GBTLI ALL-93 protocol provided the same overall outcome as 2-year duration regimen.

References Powered by Scopus

Improved survival for children and adolescents with acute lymphoblastic leukemia between 1990 and 2005: A report from the children's oncology group

941Citations
N/AReaders
Get full text

Long-term results of five consecutive trials in childhood acute lymphoblastic leukemia performed by the ALL-BFM study group from 1981 to 2000

452Citations
N/AReaders
Get full text

Prognostic importance of 6-mercaptopurine dose intensity in acute lymphoblastic leukemia

346Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Optimizing therapy in the modern age: differences in length of maintenance therapy in acute lymphoblastic leukemia

44Citations
N/AReaders
Get full text

The profile of immunophenotype and genotype aberrations in subsets of pediatric T-cell acute lymphoblastic leukemia

40Citations
N/AReaders
Get full text

Low Bioavailability and High Immunogenicity of a New Brand of E. coli L-Asparaginase with Active Host Contaminating Proteins

32Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Brandalise, S. R., Viana, M. B., Pinheiro, V. R. P., Mendonça, N., Lopes, L. F., Pereira, W. V., … Salgado, M. A. S. (2016). Shorter maintenance therapy in childhood acute lymphoblastic leukemia: The experience of the prospective, randomized Brazilian GBTLI ALL-93 Protocol. Frontiers in Pediatrics, 4(OCT). https://doi.org/10.3389/fped.2016.00110

Readers over time

‘16‘17‘18‘19‘20‘21‘22‘23‘24‘25036912

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 14

67%

Professor / Associate Prof. 4

19%

Researcher 2

10%

Lecturer / Post doc 1

5%

Readers' Discipline

Tooltip

Medicine and Dentistry 16

73%

Pharmacology, Toxicology and Pharmaceut... 2

9%

Nursing and Health Professions 2

9%

Biochemistry, Genetics and Molecular Bi... 2

9%

Article Metrics

Tooltip
Social Media
Shares, Likes & Comments: 62

Save time finding and organizing research with Mendeley

Sign up for free
0